news
RNA-binding proteins play important role in motor neurone disease
30 October 2015 | By Victoria White
The discovery about the FUS protein could be a major milestone on the path to a treatment for both motor neurone disease and dementia...
List view / Grid view
Amyotrophic Lateral Sclerosis (ALS)
news
iPSC technology helps characterise healthy and diseased neurons
23 October 2015 | By Victoria White
Using iPSC technology, researchers created 16 different cells lines, some using cells from healthy humans and others using cells from people with ALS or spinal muscular atrophy...
news
Dementia Consortium funds project focusing on ALS and FTLD
16 September 2015 | By Victoria White
A team at the International Centre for Genetic Engineering and Biotechnology (ICGEB) will join forces with MRC Technology to take on the project...
news
Gene therapy gives long-term protection to photoreceptor cells in retinitis pigmentosa model
15 July 2015 | By Victoria White
Scientists have shown that gene therapy can give protection to the light-sensitive photoreceptor cells responsible for colour vision in retinitis pigmentosa...
news
CEVEC’s CAP Go derived recombinant placental human alkaline phosphatase (PLAP) shows promise
6 July 2015 | By Victoria White
CEVEC Pharmaceuticals has announced results of a preclinical study in which CAP Go derived recombinant PLAP showed significantly prolonged serum-half-life...
news
Discovery gives hope for finding a treatment for amyotrophic lateral sclerosis
10 June 2015 | By Victoria White
A previously unknown link between the immune system and the death of motor neurons in amyotrophic lateral sclerosis has been discovered by scientists...
news
Treeway announces License and Collaboration Agreement with uniQure to develop a Gene Therapy for Amyotrophic Lateral Sclerosis
16 January 2015 | By Treeway B.V.
Treeway B.V., founded by entrepreneurs Bernard Muller and Robbert Jan Stuit, both diagnosed with ALS, have announced a collaboration with uniQure N.V., a leading gene therapy company, (NASDAQ:QURE), to develop a gene therapy treatment for ALS...
